share_log

Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

SEC ·  Mar 29 19:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more